| MR编号 | IS/H/0609/001 |
|---|
| 药品名称 | Nintedanib Teva |
|---|
| 活性成分 | - nintedanib esilate 100.0 mg
|
|---|
| 剂型 | Capsule, soft |
|---|
| 上市许可持有人 | Teva GmbH,
Graf-Arco-Str.3,
89079 Ulm,
Germany |
|---|
| 参考成员国 - 产品名称 | Iceland (IS) Nintedanib Teva |
|---|
| 互认成员国 - 产品名称 | - Greece (EL)
- Luxembourg (LU)
- Romania (RO)
Nintedanib Adalvo 100 mg capsule moi - Spain (ES)
- Czech Republic (CZ)
Nintedanib Adalvo - France (FR)
- Estonia (EE)
- Austria (AT)
- Lithuania (LT)
Nintedanib Adalvo 100 mg minkštosios kapsulės - Latvia (LV)
- Netherlands (NL)
- Poland (PL)
Nintedanib Adalvo - Belgium (BE)
Nintedanib Teva 100 mg zachte capsules - Finland (FI)
- Denmark (DK)
- Norway (NO)
- Germany (DE)
Nintedanib Adalvo 100 mg Weichkapseln - Sweden (SE)
- Slovenia (SI)
- Hungary (HU)
Nintedanob Teva 100mg lágy kapszula - Slovak Republic (SK)
- Cyprus (CY)
Nintedanib/Teva 100mg soft capsules - Croatia (HR)
- Italy (IT)
- Portugal (PT)
- Ireland (IE)
|
|---|
| 许可日期 | 2023/12/21 |
|---|
| 最近更新日期 | 2025/10/27 |
|---|
| 药物ATC编码 | | 申请类型 | - TypeLevel1：Abridged
- TypeLevel2：Initial Application
- TypeLevel3：Generic
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|